Feasibility of an Activity Control System in Patients with Diabetes: A Study Protocol of a Randomised Controlled Trial
Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The prese...
Saved in:
Published in: | Diabetes, metabolic syndrome and obesity Vol. 15; pp. 2683 - 2691 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Macclesfield
Dove Medical Press Limited
01-01-2022
Taylor & Francis Ltd Dove Dove Medical Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices. Keywords: artificial intelligence, diabetes mellitus, self-care, telemedicine |
---|---|
AbstractList | Pedro Montagut-Martínez,1 Jose Joaquin García-Arenas,2 Matilde Romero-López,3 Nicomedes Rodríguez-Rodríguez,3 David Pérez-Cruzado,2,4 Jesús González-Lama3,5 1Health Sciences PhD Program, Universidad Católica de Murcia UCAM, Murcia, 30107, Spain; 2Department of Occupational Therapy, Universidad Catolica de Murcia UCAM, Murcia, 30107, Spain; 3Cabra Clinical Management Unit, Sur de Córdoba Health Management Area, Cordoba, Spain; 4Institute of Biomedicine of Malaga (IBIMA), Málaga, Spain; 5Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, SpainCorrespondence: David Pérez-Cruzado, Department of Occupational Therapy, Universidad Catolica de Murcia UCAM, Campus de los Jerónimos n° 135, Guadalupe, Murcia, 30107, Spain, Tel +34 653141109, Email d_perez_cruzado@hotmail.comPurpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient.Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups.Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices.Keywords: artificial intelligence, diabetes mellitus, self-care, telemedicine Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices. Keywords: artificial intelligence, diabetes mellitus, self-care, telemedicine Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and Methods: A pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. Discussion: This project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices. PurposePatients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are associated with the difficulty of these patients in managing their lifestyle, which may even lead to the abandonment of treatment. The present study was designed to evaluate the feasibility of a multipurpose activity control solution for home activity (home activity control system), which will provide information on the activities of daily living carried out outside in real time, to improve adherence to each of the therapeutic objectives agreed on with the diabetic patient. Patients and MethodsA pilot randomised controlled feasibility study will be carried out to evaluate a home activity control system (Beprevent) in managing patients with type 2 diabetes mellitus. Twenty patients with type 2 diabetes mellitus will be included (10 in the intervention group and 10 in the control group). Data on satisfaction with the tool will be collected from professionals and patients, as well as other clinical/epidemiological data from their digital health records and several questionnaires, at baseline and six months. In addition, data will also be recorded regarding the degree of adherence to the behaviors agreed on with the patients before starting the study to assess changes throughout the study and their relationship with clinical results (glycosylated haemoglobin (HbA1c), cholesterol, etc), and to compare these outcomes between two study groups. DiscussionThis project involves the incorporation of telemedicine in the management of patients with diabetes. Thus, according to the currently published bibliography, the use of smart devices in this population could help improve the quality of life of these people, reduce medical visits and improve adherence to home care patterns for diabetes mellitus. There are currently no published clinical trials or protocols that monitor activities of daily living in patients with diabetes individually using artificial intelligence (AI) devices. |
Audience | Academic |
Author | García-Arenas, Jose Joaquin Rodríguez-Rodríguez, Nicomedes Pérez-Cruzado, David Romero-López, Matilde Montagut-Martínez, Pedro González-Lama, Jesús |
Author_xml | – sequence: 1 givenname: Pedro orcidid: 0000-0002-8698-6231 surname: Montagut-Martínez fullname: Montagut-Martínez, Pedro – sequence: 2 givenname: Jose Joaquin surname: García-Arenas fullname: García-Arenas, Jose Joaquin – sequence: 3 givenname: Matilde surname: Romero-López fullname: Romero-López, Matilde – sequence: 4 givenname: Nicomedes surname: Rodríguez-Rodríguez fullname: Rodríguez-Rodríguez, Nicomedes – sequence: 5 givenname: David orcidid: 0000-0001-7952-0831 surname: Pérez-Cruzado fullname: Pérez-Cruzado, David – sequence: 6 givenname: Jesús surname: González-Lama fullname: González-Lama, Jesús |
BookMark | eNptkk1vEzEQhleoiJbSGz_AEhLiQII_114OSFFKoVJRK1LOltdrJ442drG9Qfn3eEmABmEfPB6_84z8ap5XJz54U1UvEZxiRPm7yy-L2-mC1A2t6ZPqDCEuJhxCfvIoPq0uUlrDcXFIMX5WnZIaClQjdlZtr4xKrnW9yzsQLFAezHR22_E6Dz7H0IPFLmWzAc6DO5Wd8TmBHy6vwKVTrckmvQczsMhDtwN3MeSgS8lIAl-V78LGJdP9RvUlvI9O9S-qp1b1yVwczvPq29XH-_nnyc3tp-v57GaiGYJ5QoWhVmNqUWcV1rzjihBDmaa60ZZZSzW03OKmgYyZthMQG65ZjVnTkppScl5d77ldUGv5EN1GxZ0MyslfiRCXUsXsdG8kJJgjaJERClFtbduYlmpGYMO6tuO2sD7sWQ9DuzGdLkZE1R9Bj1-8W8ll2MqGUkEYKoA3B0AM3weTsizmaNP3ypswJFn6Y0FrRkmRvvpHug5D9MWqUcUQ40Kgv6qlKh9w3obSV49QOeOYYCKYEEU1_Y-q7M5snC7zZF3JHxW8flSwMqrPqxT6Ibvg07Hw7V6oY0gpGvvHDATlOJ9ynE95mE_yE9w61vQ |
Cites_doi | 10.1089/dia.2020.0656 10.2337/dc19-2519 10.1370/afm.2421 10.1249/01.MSS.0000078924.61453.FB 10.2196/18119 10.1016/S1138-6045(07)73665-1 10.1016/j.aprim.2015.08.005 10.1080/03091902.2022.2089249 10.1016/0021-9681(87)90171-8 10.1097/00005650-198601000-00007 10.1900/RDS.2010.7.252 10.1111/bcp.12194 10.1016/S2213-8587(18)30051-2 10.2196/29178 10.3390/ijerph19106128 10.1111/dme.13958 10.1590/1980-220x-reeusp-2021-0295 10.2337/dc16-0614 10.1186/1471-2458-9-31 10.2196/31832 10.2337/diacare.24.1.16 10.1080/10408398.2010.500258 10.1136/bmj.e7586 10.1177/0145721720913276 10.1016/S2213-8587(18)30203-1 10.1016/j.diabres.2018.02.023 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 Dove Medical Press Limited 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Montagut-Martínez et al. 2022 Montagut-Martínez et al. |
Copyright_xml | – notice: COPYRIGHT 2022 Dove Medical Press Limited – notice: 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Montagut-Martínez et al. 2022 Montagut-Martínez et al. |
DBID | AAYXX CITATION 3V. 7RV 7XB 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH GNUQQ GUQSH KB0 M2O MBDVC NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/DMSO.S369464 |
DatabaseName | CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database (ProQuest) ProQuest Central (purchase pre-March 2016) ProQuest Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Nursing & Allied Health Database (Alumni Edition) ProQuest research library Research Library (Corporate) Nursing & Allied Health Premium Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection ProQuest Central Korea ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Montagut-Martínez et al |
EISSN | 1178-7007 |
EndPage | 2691 |
ExternalDocumentID | oai_doaj_org_article_032710f1e8a14cffb9eb4c53095dbd7f A723238588 10_2147_DMSO_S369464 |
GeographicLocations | Spain |
GeographicLocations_xml | – name: Spain |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 0YH 29F 2WC 53G 5VS 7RV 8C1 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD EBS EJD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M2O M48 M~E NAPCQ O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RNS RPM TDBHL TR2 UKHRP VDV 3V. 7XB 8FK COVID MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c510t-48e4fc24f1dfa2c7d7a33e45c4c9cf5ff4c0f7f299055ebd802e7c56259b36443 |
IEDL.DBID | RPM |
ISSN | 1178-7007 |
IngestDate | Tue Oct 22 15:14:48 EDT 2024 Tue Sep 17 21:25:17 EDT 2024 Fri Aug 16 23:57:21 EDT 2024 Fri Nov 08 02:17:29 EST 2024 Tue Nov 19 21:06:41 EST 2024 Tue Nov 12 22:55:19 EST 2024 Tue Aug 20 22:13:23 EDT 2024 Thu Nov 21 23:52:06 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c510t-48e4fc24f1dfa2c7d7a33e45c4c9cf5ff4c0f7f299055ebd802e7c56259b36443 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7952-0831 0000-0002-8698-6231 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448351/ |
PMID | 36081615 |
PQID | 2715157881 |
PQPubID | 3933170 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_032710f1e8a14cffb9eb4c53095dbd7f pubmedcentral_primary_oai_pubmedcentral_nih_gov_9448351 proquest_miscellaneous_2712846543 proquest_journals_2715157881 gale_infotracmisc_A723238588 gale_infotracacademiconefile_A723238588 gale_healthsolutions_A723238588 crossref_primary_10_2147_DMSO_S369464 |
PublicationCentury | 2000 |
PublicationDate | 2022-01-01 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Macclesfield |
PublicationPlace_xml | – name: Macclesfield |
PublicationTitle | Diabetes, metabolic syndrome and obesity |
PublicationYear | 2022 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
References | Shankaracharya Odedra (ref8) 2010; 7 Baena-Díez (ref1) 2016; 39 May (ref12) 2021; 23 ref15 Craig (ref23) 2003; 35 Nguyen (ref19) 2014; 77 Fernandez (ref30) 1998; 10 Clark (ref16) 2020 Val Jiménez (ref20) 1992; 10 Torres (ref31) 2005; 33 Caro-Bautista (ref22) 2016; 48 Brooke (ref27) 1996; 189 Charlson (ref18) 1987; 40 Hills (ref2) 2018; 6 Morisky (ref21) 1986; 24 Cho (ref3) 2018; 138 Garg (ref13) 2021; 23 Garcia (ref17) 2001; 24 Moody (ref10) 2022 Brooke (ref26) 2013; 8 Jamal (ref7) 2021; 6 ref28 Correia (ref11) 2022; 19 ref29 Chan (ref14) 2013; 346 Seng (ref33) 2020; 43 Ahlqvist (ref34) 2018; 6 Dambha-Miller (ref5) 2019; 17 Negreiros (ref9) 2021; 55 Giné-Garriga (ref24) 2009; 9 Lazarou (ref4) 2012; 52 Mueller (ref6) 2022; 7 Mantilla Toloza (ref25) 2007; 10 Holt (ref32) 2019; 36 |
References_xml | – volume: 23 start-page: S15 year: 2021 ident: ref13 publication-title: Diabetes Technol Ther doi: 10.1089/dia.2020.0656 contributor: fullname: Garg – volume: 43 start-page: 1048 year: 2020 ident: ref33 publication-title: Diabetes Care doi: 10.2337/dc19-2519 contributor: fullname: Seng – volume: 17 start-page: 311 year: 2019 ident: ref5 publication-title: Ann Fam Med doi: 10.1370/afm.2421 contributor: fullname: Dambha-Miller – volume: 35 start-page: 1381 year: 2003 ident: ref23 publication-title: Med Sci Sports Exerc doi: 10.1249/01.MSS.0000078924.61453.FB contributor: fullname: Craig – volume: 23 start-page: e18119 year: 2021 ident: ref12 publication-title: J Med Internet Res doi: 10.2196/18119 contributor: fullname: May – volume: 10 start-page: 48 year: 2007 ident: ref25 publication-title: Revista Iberoamericana de Fisioterapia y Kinesiología doi: 10.1016/S1138-6045(07)73665-1 contributor: fullname: Mantilla Toloza – ident: ref29 – volume: 48 start-page: 458 year: 2016 ident: ref22 publication-title: Aten Primaria doi: 10.1016/j.aprim.2015.08.005 contributor: fullname: Caro-Bautista – start-page: 1 year: 2022 ident: ref10 publication-title: J Med Eng Technol doi: 10.1080/03091902.2022.2089249 contributor: fullname: Moody – volume: 40 start-page: 373 year: 1987 ident: ref18 publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 contributor: fullname: Charlson – volume: 33 start-page: 216 year: 2005 ident: ref31 publication-title: Actas Esp Psiquiatr contributor: fullname: Torres – volume: 10 start-page: 767 year: 1992 ident: ref20 publication-title: Aten Primaria contributor: fullname: Val Jiménez – volume: 24 start-page: 67 year: 1986 ident: ref21 publication-title: Med Care doi: 10.1097/00005650-198601000-00007 contributor: fullname: Morisky – volume: 7 start-page: 252 year: 2010 ident: ref8 publication-title: Rev Diabet Stud doi: 10.1900/RDS.2010.7.252 contributor: fullname: Shankaracharya Odedra – volume: 77 start-page: 427 year: 2014 ident: ref19 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12194 contributor: fullname: Nguyen – ident: ref15 – volume: 6 start-page: 361 year: 2018 ident: ref34 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(18)30051-2 contributor: fullname: Ahlqvist – volume: 6 start-page: e29178 year: 2021 ident: ref7 publication-title: JMIR Diabetes doi: 10.2196/29178 contributor: fullname: Jamal – volume: 19 start-page: 6128 year: 2022 ident: ref11 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph19106128 contributor: fullname: Correia – volume: 36 start-page: 529 year: 2019 ident: ref32 publication-title: Diabet Med doi: 10.1111/dme.13958 contributor: fullname: Holt – volume: 55 start-page: e20210295 year: 2021 ident: ref9 publication-title: Rev Esc Enferm USP doi: 10.1590/1980-220x-reeusp-2021-0295 contributor: fullname: Negreiros – volume: 39 start-page: 1987 year: 2016 ident: ref1 publication-title: Diabetes Care doi: 10.2337/dc16-0614 contributor: fullname: Baena-Díez – volume: 9 start-page: 31 year: 2009 ident: ref24 publication-title: BMC Public Health doi: 10.1186/1471-2458-9-31 contributor: fullname: Giné-Garriga – volume: 10 start-page: 459 year: 1998 ident: ref30 publication-title: Psicothema-Oviedo contributor: fullname: Fernandez – volume: 7 start-page: e31832 year: 2022 ident: ref6 publication-title: JMIR Diabetes doi: 10.2196/31832 contributor: fullname: Mueller – ident: ref28 – volume: 8 start-page: 29 year: 2013 ident: ref26 publication-title: J Usability Stud contributor: fullname: Brooke – volume: 189 start-page: 4 year: 1996 ident: ref27 publication-title: Usability Eval Ind contributor: fullname: Brooke – volume: 24 start-page: 16 year: 2001 ident: ref17 publication-title: Diabetes Care doi: 10.2337/diacare.24.1.16 contributor: fullname: Garcia – volume: 52 start-page: 382 year: 2012 ident: ref4 publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2010.500258 contributor: fullname: Lazarou – volume: 346 start-page: e7586 year: 2013 ident: ref14 publication-title: BMJ doi: 10.1136/bmj.e7586 contributor: fullname: Chan – start-page: 0145721720913276 year: 2020 ident: ref16 publication-title: Diabetes Educ doi: 10.1177/0145721720913276 contributor: fullname: Clark – volume: 6 start-page: 992 year: 2018 ident: ref2 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(18)30203-1 contributor: fullname: Hills – volume: 138 start-page: 271 year: 2018 ident: ref3 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2018.02.023 contributor: fullname: Cho |
SSID | ssj0000070422 |
Score | 2.2960618 |
Snippet | Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be lifethreatening. These problems are... Purpose: Patients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems... PurposePatients with diabetes mellitus have an increased risk of developing various serious health problems that could be life-threatening. These problems are... Pedro Montagut-Martínez,1 Jose Joaquin García-Arenas,2 Matilde Romero-López,3 Nicomedes Rodríguez-Rodríguez,3 David Pérez-Cruzado,2,4 Jesús González-Lama3,5... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 2683 |
SubjectTerms | Activities of daily living Artificial intelligence Care and treatment Clinical trials Control systems Diabetes diabetes mellitus Diabetes therapy Diabetics Glycosylated hemoglobin Health aspects Home care Intervention Medical records Medical research Medicine, Experimental Nutrition research Pathology Patients Questionnaires self-care Study Protocol Telemedicine Type 2 diabetes |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VHiouiPIQKS0YqYhTaOI4scNt6UO9tFRskbhZiR-iEkqq7i5S_z0ztnfVwIELtySeWMk84s_O-BuAQ6dUbbkq8t5InxMmz1tLyTS-4X1jW8sNLbidz-Xld3VySjQ5m1JflBMW6YGj4o6KiuMg6EunulIY7_vW9cLUFUID21vpw9e3aB5MpiLwlURuFSurqFziecx6p7I8RycX8y8f51XTikZMxqNA2__3x_nPhMkHI9DZU3iSoCObxUfehS03PIOdi_Rz_Dn8QjiXkl3v2ehZN7CZicUh2HHMSGeRoJzdDOwqEqouGK3EspQYs_jEZoxSC-_Z1d24HNFLQk_sazfYEV3C2XVXP_Hwmrz3BXw7O70-Ps9TWYXcYAAuc6Gc8IYLX1rfcSOt7KrKidoI0xpfey9M4aWncaquXW9VwZ00YaLUVwifqpewPYyDewWM-AN9KWxRdEI4X3StLC0R6remxK55Bu_XytW3kT1D46yDjKDJCDoZIYPPpPmNDHFehwvoCTp5gv6XJ2Twluym4wbSTeTqmUTUSP8_VQYfggTFLtrRdGkLAr4MsWBNJPcnkqhgM21e-4ZOMb_Q-HQIDomeP4N3m2a6k_LYBjeuggziAdrPm4Gc-NTk3actw82PwPvd4lS6qsu9_6Gs1_CY00aOsJi0D9vLu5U7gEcLu3oTIuk3648imA priority: 102 providerName: Directory of Open Access Journals |
Title | Feasibility of an Activity Control System in Patients with Diabetes: A Study Protocol of a Randomised Controlled Trial |
URI | https://www.proquest.com/docview/2715157881 https://search.proquest.com/docview/2712846543 https://pubmed.ncbi.nlm.nih.gov/PMC9448351 https://doaj.org/article/032710f1e8a14cffb9eb4c53095dbd7f |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPSAuiKcIlGIkEKfs5uHECbdl26qXhRVbJG5W4kdZqU2qfVTqv--M46w2cOO2iidW4plZf3Y-fwPwyRRFppMiCmslbEiYPCw1kWlsntS5LnWiaMPtYim-_y5Oz0gmJ-vPwjjSvqpX4-b6Ztys_jhu5e2NmvQ8scliPitxTZFm8WQEI8SGB0v0DvMK0rXqSO5UhWdyOl_-GC_TvOQ5leFJcyo2QXVwD2YiJ9j_79_y31TJg7nn_Bk89aCRTbuHew6PTPMCHs_9Z_GXcIdAztNc71lrWdWwqerKQrBZx0VnnTQ5WzVs0UmpbhjtwTJPidl8ZVNGpMJ7tli32xbjw_XEflaNbjEYjO67usaflxS3r-DX-dnl7CL0BRVCham3DXlhuFUJt7G2VaKEFlWaGp4prkplM2u5iqywNENlmal1ESVGKLdEqlMETulrOGraxrwBRsqBNuY6iirOjY2qUsSapPRLFWPXSQCf-8GVt51uhsT1BvlDkj-k90cA32jk9zakdu0utOsr6X0uozRBIGRjU1QxV9bWpam5ylKEh7rWwgbwgfwmu6Oj-5yVU4F4kb58FgF8cRaUtehHVfnDB_gypH81sDweWOIAq2FzHxvSZ_tG4tMhLCRh_gA-7pvpTmKwNabdORtEAnSSNwAxiKnBuw9bMAGc4rcP-Lf_fec7eJLQuQ23d3QMR9v1zryH0UbvTtwuxInLoQdNayFk |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7RIgEX3ghDoYsE4uTEj7XX5hbSVkE0JSJB4ray9wGRWrvKA6n_npm1HcVw683yrle2Z8b77fqbbwDemyxLdJQFfqmE9QmT-7kmMo1NozLVuY4UbbhN5uLiZ3ZySjI5SZcL40j7qlwOqsurQbX87biV11dq2PHEhrPpOMc1RZyEwwO4i_EaBHuL9Ab1ClK2amjuVIdneDKdfxvM4zTnKRXiiVMqN0GVcPfmIifZ__-H-V-y5N7sc_bolvf9GB62cJONmuYncMdUT-HetP2h_gz-IARsCbI3rLasqNhINQUl2LhhsbNG1JwtKzZrRFjXjHZvWUumWX9iI0Z0xBs2W9WbGj3LjcS-F5Wu0Y2M7oa6xMMFefxz-HF2uhhP_LYUg68waDc-zwy3KuI21LaIlNCiiGPDE8VVrmxiLVeBFZbmtiQxpc6CyAjlFldljJArfgGHVV2Zl8BIc9CGXAdBwbmxQZGLUJMIf65CHDry4ENnFHndKG5IXKmQHSXZUbZ29OAzWWzXh3Sy3Yl69Uu2b10GcYQQyoYmK0KurC1zU3KVxAgsdamF9eCY7C2bpNNdtMuRQKRJ_0wzDz66HhTvaH9VtGkL-DCknNXredTriS9Y9Zs7n5Ltd2It8e4QUJKkvwfvds10JXHfKlNvXR_EEJQD7IHo-WLv2fst6IJOK7x1uVe3vvIY7k8W03N5_uXi62t4EFH2h9uBOoLDzWpr3sDBWm_fugj8C4d2Nfk |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RIlVcKE_VtNBFAnFy4sfaa3MLSaMiSIlIkbit7H1ApNaO8kDqv2dm7UQx3OBmeccr2zPj_Xb97TcAb0yWJTrKAr9UwvqEyf1cE5nGplGZ6lxHihbcLmfi6ns2uiCZnF2pL0faV-W8V93c9qr5T8etXNyq_pYn1p9OhjnOKeIk7C-07R_AfczZINqbqDfIV5C6VUN1p1o8_dFk9qU3i9Ocp1SMJ06p5ARVw90bj5xs_98f5z8Jk3sj0Pj4P-79ETxsYScbNCaP4Z6pnsDRpP2x_hR-IRRsibJ3rLasqNhANYUl2LBhs7NG3JzNKzZtxFhXjFZxWUuqWb1nA0a0xDs2XdbrGiPM9cS-FpWuMZyM3nZ1g4fXFPnP4Nv44np46bclGXyFybv2eWa4VRG3obZFpIQWRRwbniiucmUTa7kKrLA0xiWJKTU6xgjlJllljNArfg6HVV2ZE2CkPWhDroOg4NzYoMhFqEmMP1chdh158HbrGLlolDckzljIl5J8KVtfevCBvLazIb1sd6Je_pDtm5dBHCGUsqHJipAra8vclFwlMQJMXWphPTgnn8tm8-ku6-VAIOKkf6eZB--cBeU9xoAq2u0L-DCkoNWxPOtY4gtW3eZtXMn2e7GSeHcILEna34PXu2a6kjhwlak3zgaxBO0F9kB04rHz7N0WDEOnGd6G3Yt_vvIcjqajsfz88erTKTyIaBOIW4g6g8P1cmNewsFKb165JPwNMI84eQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feasibility+of+an+Activity+Control+System+in+Patients+with+Diabetes%3A+A+Study+Protocol+of+a+Randomised+Controlled+Trial&rft.jtitle=Diabetes%2C+metabolic+syndrome+and+obesity&rft.au=Montagut-Mart%C3%ADnez%2C+Pedro&rft.au=Garc%C3%ADa-Arenas%2C+Jose+Joaquin&rft.au=Romero-L%C3%B3pez%2C+Matilde&rft.au=Rodr%C3%ADguez-Rodr%C3%ADguez%2C+Nicomedes&rft.date=2022-01-01&rft.issn=1178-7007&rft.eissn=1178-7007&rft.volume=15&rft.spage=2683&rft.epage=2691&rft_id=info:doi/10.2147%2FDMSO.S369464&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7007&client=summon |